PTAB Mulls Analogous Prior Art In Sanofi, Mylan Injector Case

Law360 (January 13, 2021, 6:55 PM EST) -- An attorney for Sanofi-Aventis received some pushback Wednesday from a Patent Trial and Appeal Board judge as he argued that a prior art reference from the automotive field that Mylan asserted in its challenge to Sanofi's injector pen patent can't be used to render it invalid.

The argument from Fish & Richardson attorney Karl Renner came during a remote morning hearing and marks the latest development in Mylan's challenges to Sanofi's injection pen patents as Mylan has sought to market its own generics.

At the heart of Wednesday's hearing was whether an earlier patent that Mylan asserted relates to the problem...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!